Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Baum

Showing results (221-230 of 470) with videos related to

Pageof 47
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|July 23, 2014
The future of nuclear medicine imaging of neuroendocrine tumors: on a clear day one might see foreverLisa Bodei, Mark Kidd, Vikas Prasad, et al.
Future Oncology (London, England)|November 8, 2012
EDIM-TKTL1 blood test: a noninvasive method to detect upregulated glucose metabolism in patients with malignanciesOliver Feyen, Johannes F Coy, Vikas Prasad, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEAA Hertel, R P Baum, M Lorenz, et al.
The Journal of Pathology|August 1, 1988
Chromophobe cell renal carcinoma and its variants--a report on 32 casesW Thoenes, S Störkel, H J Rumpelt, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against gamma-glutamyltransferaseP Fischer, R P Baum, M Tauber, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
The Bad Berka dose protocol: comparative results of dosimetry in peptide receptor radionuclide therapy using (177)Lu-DOTATATE, (177)Lu-DOTANOC, and (177)Lu-DOTATOCChristiane Schuchardt, Harshad R Kulkarni, Vikas Prasad, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Clinical and clinico-chemical follow-up controls in pancreatic necrosis]H Schönborn, W Prellwitz, H P Schuster, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Prognostic Value of <sup>18</sup>F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide TherapyJingjing Zhang, Qingxing Liu, Aviral Singh, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|June 20, 2015
[Unusual finding in a 50-year-old patient with lumboischialgia and unilateral foot drop]T Hiegel, D Zajonz, P Baum, et al.
Frontiers in Endocrinology|July 9, 2025
The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapyAviral Singh, Sebastian Sanduleanu, Harshad R Kulkarni, et al.
Pageof 47

Showing results (221-230 of 470) with videos related to

Sort By:
Pageof 47
European Journal of Nuclear Medicine and Molecular Imaging|July 23, 2014
The future of nuclear medicine imaging of neuroendocrine tumors: on a clear day one might see foreverLisa Bodei, Mark Kidd, Vikas Prasad, et al.
Future Oncology (London, England)|November 8, 2012
EDIM-TKTL1 blood test: a noninvasive method to detect upregulated glucose metabolism in patients with malignanciesOliver Feyen, Johannes F Coy, Vikas Prasad, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEAA Hertel, R P Baum, M Lorenz, et al.
The Journal of Pathology|August 1, 1988
Chromophobe cell renal carcinoma and its variants--a report on 32 casesW Thoenes, S Störkel, H J Rumpelt, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against gamma-glutamyltransferaseP Fischer, R P Baum, M Tauber, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
The Bad Berka dose protocol: comparative results of dosimetry in peptide receptor radionuclide therapy using (177)Lu-DOTATATE, (177)Lu-DOTANOC, and (177)Lu-DOTATOCChristiane Schuchardt, Harshad R Kulkarni, Vikas Prasad, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1971
[Clinical and clinico-chemical follow-up controls in pancreatic necrosis]H Schönborn, W Prellwitz, H P Schuster, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Prognostic Value of <sup>18</sup>F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide TherapyJingjing Zhang, Qingxing Liu, Aviral Singh, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|June 20, 2015
[Unusual finding in a 50-year-old patient with lumboischialgia and unilateral foot drop]T Hiegel, D Zajonz, P Baum, et al.
Frontiers in Endocrinology|July 9, 2025
The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapyAviral Singh, Sebastian Sanduleanu, Harshad R Kulkarni, et al.
Pageof 47